IL94979A - Antiherpes pentapeptides, their preparation, and pharmaceutical and cosmetic compositions containing them - Google Patents

Antiherpes pentapeptides, their preparation, and pharmaceutical and cosmetic compositions containing them

Info

Publication number
IL94979A
IL94979A IL9497990A IL9497990A IL94979A IL 94979 A IL94979 A IL 94979A IL 9497990 A IL9497990 A IL 9497990A IL 9497990 A IL9497990 A IL 9497990A IL 94979 A IL94979 A IL 94979A
Authority
IL
Israel
Prior art keywords
peptide
alkyl
phenyl
acceptable salt
asp
Prior art date
Application number
IL9497990A
Other languages
English (en)
Other versions
IL94979A0 (en
Original Assignee
Bio Mago Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mago Boehringer Ingelheim filed Critical Bio Mago Boehringer Ingelheim
Publication of IL94979A0 publication Critical patent/IL94979A0/xx
Publication of IL94979A publication Critical patent/IL94979A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IL9497990A 1989-07-07 1990-07-05 Antiherpes pentapeptides, their preparation, and pharmaceutical and cosmetic compositions containing them IL94979A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000605092A CA1340684C (en) 1989-07-07 1989-07-07 Antiherpes pentapeptides

Publications (2)

Publication Number Publication Date
IL94979A0 IL94979A0 (en) 1991-06-10
IL94979A true IL94979A (en) 1995-03-30

Family

ID=4140318

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9497990A IL94979A (en) 1989-07-07 1990-07-05 Antiherpes pentapeptides, their preparation, and pharmaceutical and cosmetic compositions containing them

Country Status (8)

Country Link
EP (1) EP0408973B1 (de)
JP (1) JP2877908B2 (de)
AT (1) ATE144534T1 (de)
AU (1) AU644085B2 (de)
CA (1) CA1340684C (de)
DE (1) DE69028953T2 (de)
IL (1) IL94979A (de)
NZ (1) NZ234374A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340682C (en) * 1989-07-07 1999-07-27 Pierre Lavallee Antiviral peptides having a 2-oxoalkyl amino acid side chain
EP0560267B1 (de) 1992-03-12 1998-08-19 Boehringer Ingelheim (Canada) Ltd. Isosterische Peptidderivate gegen Herpes
US5846941A (en) * 1992-03-12 1998-12-08 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives II
WO2020053654A1 (en) 2018-09-12 2020-03-19 Novartis Ag Antiviral pyridopyrazinedione compounds
CN114667285B (zh) 2019-09-26 2025-08-08 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795740A (en) * 1986-05-20 1989-01-03 Cohen Eric A Antiviral peptides and means for treating herpes infections
EP0292255A3 (de) * 1987-05-22 1990-08-22 Merck & Co. Inc. Hemmungsstoff für Ribonukleotid-Reduktase

Also Published As

Publication number Publication date
AU5877890A (en) 1991-01-10
EP0408973A1 (de) 1991-01-23
AU644085B2 (en) 1993-12-02
ATE144534T1 (de) 1996-11-15
NZ234374A (en) 1997-06-24
IL94979A0 (en) 1991-06-10
CA1340684C (en) 1999-07-27
JP2877908B2 (ja) 1999-04-05
DE69028953D1 (de) 1996-11-28
EP0408973B1 (de) 1996-10-23
DE69028953T2 (de) 1997-02-20
JPH03101696A (ja) 1991-04-26

Similar Documents

Publication Publication Date Title
EP0461546B1 (de) Antiherpes-Peptidderivate mit einem 1,4-Dioxo-C4-N-Terminus
CA1340681C (en) Antiherpes tetrapeptides having a substituted aspartic acid side chain
US5552384A (en) Antiherpes compositions and method of use
US5700780A (en) Antiviral peptide derivatives having a 2-oxoalkyl amino acid side chain
CA1340684C (en) Antiherpes pentapeptides
EP0411334B1 (de) Pentapeptidderivate, wirksam gegen Herpes, die eine ersetzte Asparaginsäureseitenkette enthalten
CA1340683C (en) Antiherpes pentapeptides having a substituted aspartic acid side chain
AU683450B2 (en) Inhibitors of herpes viral ribonucleotide reductase
US5648337A (en) Antiherpes pentapeptides
US5149778A (en) Cyclic peptides for treating herpes infections
EP0411333B1 (de) Antiherpes-Tetrapeptid-Derivate mit einer substituierten Seitenkette aus Asparaginsäure
US5258493A (en) Cyclic peptides for treating herpes infections
CA2019005C (en) Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
CA2019006C (en) Antiherpes tetrapeptide derivatives having a cycloalkyl substituted aspartic acid side chain
NZ234373A (en) Acylated n-terminal tetrapeptides having an esterified or amidified aspartic acid residue and optionally substituted at the c-terminal by 5-1h-tetrazolyl; use in treatment of herpes virus infections

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void